Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03931031 · ClinicalTrials.gov registry record
Pre-surgical Evaluation for the Quantra System in Adult Patients Undergoing Cardiac Surgery
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 40
- Enrollment target
NCT03931031: Completed study, sponsored by HemoSonics.
NCT03931031 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03931031 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QPlus Cartridge in patients taking anitplatelet medication that are scheduled to undergo cardiac surgery.
Primary Outcome
Coagulation function assessed by Quantra and TEG.
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-03-21 |
| Est. Completion | 2020-06-27 |
What the finished NCT03931031 record still lists
NCT03931031 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT03931031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03931031 about?
NCT03931031 is a clinical study titled "Pre-surgical Evaluation for the Quantra System in Adult Patients Undergoing Cardiac Surgery". This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QPlus Cartridge in patients taking anitplatelet medication that are scheduled to undergo cardiac surgery.
What is the current status of trial NCT03931031?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2019-03-21. Estimated completion is 2020-06-27.
What interventions are being tested in trial NCT03931031?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03931031?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI